GlassScriptPhysician profile
Manish Sharma
NPI 1982652574
$514.70
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $358 · 2020: $98.40 · 2021: $58.72.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $141.17 | 2019 | |
| Daiichi Sankyo INC. | $125.67 | 2019 | |
| Melinta Therapeutics, LLC | $90.22 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $45.41 | 2019-2020 | |
| Abbvie INC. | $33.95 | 2021 | |
| Philips North America LLC | $24.77 | 2021 | |
| Becton, Dickinson and Company | $19.14 | 2019 | |
| Eisai INC. | $17.71 | 2020 | |
| Allergan, INC. | $16.66 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manish Sharma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.